Search research articles
Contact Us
Filters
Showing results (131-140 of 140) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 140 results.
The Lancet. Oncology
|
January 21, 2015
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study
Jeffrey D Bradley, Rebecca Paulus, Ritsuko Komaki, et al.
JAMA Oncology
|
November 26, 2015
Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial
Benjamin Movsas, Chen Hu, Jeffrey Sloan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 8, 2017
Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases
Chiachien Jake Wang, Alana Christie, Mu-Han Lin, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 14, 2021
SABR for High-Risk Prostate Cancer: A Prospective Multilevel MRI-Based Dose Escalation Trial
Raquibul Hannan, Samer Salamekh, Neil B Desai, et al.
Cancers
|
December 24, 2021
Higher Radiation Dose to the Immune Cells Correlates with Worse Tumor Control and Overall Survival in Patients with Stage III NSCLC: A Secondary Analysis of RTOG0617
Jian-Yue Jin, Chen Hu, Ying Xiao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 31, 2016
Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial
Stephen G Chun, Chen Hu, Hak Choy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2019
Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer
Jeffrey D Bradley, Chen Hu, Ritsuko R Komaki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 4, 2019
Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial
Andrea Bezjak, Rebecca Paulus, Laurie E Gaspar, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 5, 2018
Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer
Gregory M Videtic, Rebecca Paulus, Anurag K Singh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 23, 2021
Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma
Raquibul Hannan, Osama Mohamad, Alberto Diaz de Leon, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 140) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 140 results.
The Lancet. Oncology
|
January 21, 2015
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study
Jeffrey D Bradley, Rebecca Paulus, Ritsuko Komaki, et al.
JAMA Oncology
|
November 26, 2015
Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial
Benjamin Movsas, Chen Hu, Jeffrey Sloan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 8, 2017
Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases
Chiachien Jake Wang, Alana Christie, Mu-Han Lin, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 14, 2021
SABR for High-Risk Prostate Cancer: A Prospective Multilevel MRI-Based Dose Escalation Trial
Raquibul Hannan, Samer Salamekh, Neil B Desai, et al.
Cancers
|
December 24, 2021
Higher Radiation Dose to the Immune Cells Correlates with Worse Tumor Control and Overall Survival in Patients with Stage III NSCLC: A Secondary Analysis of RTOG0617
Jian-Yue Jin, Chen Hu, Ying Xiao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 31, 2016
Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial
Stephen G Chun, Chen Hu, Hak Choy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2019
Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer
Jeffrey D Bradley, Chen Hu, Ritsuko R Komaki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 4, 2019
Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial
Andrea Bezjak, Rebecca Paulus, Laurie E Gaspar, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 5, 2018
Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer
Gregory M Videtic, Rebecca Paulus, Anurag K Singh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 23, 2021
Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma
Raquibul Hannan, Osama Mohamad, Alberto Diaz de Leon, et al.
Page
of 14